Pulmatrix Inc (PULM)

[riskon]

When your motto is "Changing medicine with a new generation of pulmonary therapeutics" -- and from the JnJ webinar on alternative delivery devices the closing statement was "biggest challenge is getting pharmaceutical companies on board"....

And then you look at who Pulmatrix's partners are being:
*Largest Pharmaceutical Company in the World
*Largest Inhalation Pharmaceutical Company in India
*Novel startup with developers of iSPERSE serving as the CEO and Product Development lead of new field
*Spinoff company lead by the founder of iSPERSE/FEND focused on commercializing FEND worldwide

It should be clear what is about to happen here. If we don't get bought out straight up by JnJ, we will go well past $100+ in 2021.



$PULM